Jim Cramer goes over the best and worst Q3 performers on the Dow

Jim Cramer goes over the best and worst Q3 performers on the Dow


Cramer says Walmart and Apple are two of the Dow's biggest winners during Q3

CNBC’s Jim Cramer on Monday named the biggest losers and winners on the Dow Jones Industrial Average during the third quarter.

“Anything economically sensitive has been crushed and even high-dividend yields are no protection when the Fed is on the warpath,” he said.

Here are the winners:

Winners 

  1. Walmart
  2. Apple
  3. Home Depot
  4. Disney
  5. Chevron

Stocks have declined dramatically this year due to persistent inflation, the Federal Reserve’s interest rate hikes, Russia’s invasion of Ukraine and Covid-19 lockdowns. The market has remained volatile as Wall Street worries about a potential recession.

As for the losers, Cramer noted that many of them have high dividends.

“In a Fed-mandated bear market like this one … dividends, well, they offer you no protection whatsoever,” he said, adding that high-yielding stocks can be even more dangerous than lower yielders, because a high yield is a sign the company might need to cut the payout.

Here are the losers:

Losers

  1. Intel
  2. Verizon
  3. Nike
  4. Walgreens
  5. IBM

Disclaimer: Cramer’s Charitable Trust owns shares of Apple and Disney.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More